Posted by Michael Wonder on 03 Dec 2020
PHARMAC probe unlikely to examine commercial details - Little
3 December 2020 - Work has started on setting up an inquiry into PHARMAC but it's unlikely to have access to commercial information.
There have been calls for an inquiry into how the drug buying agency makes its decisions, and how it prioritises the drugs it funds.
Today an opposition attempt to hold a select committee inquiry was voted down.
